Andy Pasternak, EVP, Chief Strategy Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 54,258 shares at $113.03 ($6.1M) on 2023-01-17, disclosed to the SEC on 2023-01-18.
Open-market sale of $6.1M HZNP by EVP, Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.03 | 27,129 | $3.1M | 50.0% |
| 2 | $113.03 | 27,129 | $3.1M | 50.0% |
| Total | $113.03 avg | 54,258 | $6.1M | 100% |
| Filing → |
| HZNP | SELL | 2022-06-13 | $130K | — | Filing → |
| HZNP | SELL | 2022-02-18 | $249K | — | Filing → |
| HZNP | SELL | 2022-01-06 | $1.4M | — | Filing → |